Eugene I. Gordon

EUGENE I. GORDON is Founder, Chairman and CEO of Medjet Inc., which
develops surgery equipment. He is also Adjunct Professor in the
Department of Ophthalmology at the University of Medicine and Dentistry
of New Jersey. He is a well-known Scientist and Engineer. Dr. Gordon has
over 65 US patents and has published about 50 papers in peer-reviewed
journals. He is an elected member of the prestigious National Academy of
Engineering, a Fellow of the IEEE (Institute of Electrical and
Electronic Engineering), and has been awarded the IEEE Edison Medal (one
of IEEE’s highest awards) and the IEEE Zworykin Field award, as well as
numerous other awards. He has been active professionally. He founded one
IEEE Society, (the predecessor of the Lasers and Electro-Optics Society,
LEOS), and two IEEE journals, (Journal of Quantum Electronics and
Electron Device Letters), has served as Associate Editor of two IEEE
journals, and been active in Publications and Awards for many years. He
was a consultant for DOD and was Chairman of Working Group C of the
Advisory Group on Electron Devices from 1970 ‘ 1981 and a board member
of AGED from 1981 ‘ 1984. AGED is a committee of DOD. He graduated from
City College of New York, Magna cum Laude, in 1952. After graduation
from MIT with a PhD in Physics, he did a year of post-doctoral research
and teaching there. He then joined the staff of AT&T Bell Laboratories,
Murray Hill, NJ in 1957. He had several promotions and eventually became
a Laboratory Director in 1968. Dr. Gordon retired from AT&T in 1983 and
founded Lytel, Inc. of Somerville, NJ, a manufacturer of lasers and
optical transmission subsystems; he was Chairman and CEO. Lytel was
acquired by AMP, Inc. (and is now a division of the company). He then
joined Hughes Aircraft Company as Senior Vice President and Director of
their Research Labs located in Malibu, CA in 1987. He also helped to
found Taunton Technology of Monroe, CT, (now known as VISX on the NY
Stock Exchange); a company that makes refractive correction equipment,
based on excimer lasers. The latter is an outgrowth of his strong
interest in medical uses of lasers, a research area to which he made
early, important contributions; for example, Dr. Gordon invented the
argon ion laser and developed it for use in diabetic retinopathy. He
continues work in development of devices for ophthalmology at Medjet. He
is on the Board of Directors of several biotechnology companies.